Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,252.80
(
-1.87%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
79,070.38
(
0.02%
)
News Focus
News Focus
Post# of 57939
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 98
Posts 38916
Boards Moderated 89
Alias Born 03/22/2005

gfp927z

Re: bladerunner1717 post# 7668

Thursday, 07/26/2007 12:02:33 PM

Thursday, July 26, 2007 12:02:33 PM

Post# of 57939
Bladerunner, OT - Concerning Satraplatin, I understand that the FDA is now questioning the validity of the endpoint itself used in the Satraplatin trial, with the FDA now saying that they previously expressed concerns to the company over the unorthodox endpoints. But did GPC have an SPA agreeing to those endpoints prior to the trial?


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today